VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $11,811,000 | -26.2% | 13,421,283 | +4.0% | 0.21% | -17.7% |
Q1 2022 | $16,008,000 | -36.4% | 12,909,283 | 0.0% | 0.26% | -19.8% |
Q4 2021 | $25,173,000 | -28.8% | 12,909,283 | 0.0% | 0.32% | -16.7% |
Q3 2021 | $35,371,000 | -22.4% | 12,909,283 | -10.8% | 0.39% | -15.6% |
Q2 2021 | $45,574,000 | +148.7% | 14,467,872 | +68.2% | 0.46% | +169.6% |
Q1 2021 | $18,327,000 | +26.0% | 8,604,000 | +14.7% | 0.17% | +34.6% |
Q4 2020 | $14,550,000 | – | 7,500,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |